These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 28332624

  • 1. Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases.
    Fan Y, Xu Y, Gong L, Fang L, Lu H, Qin J, Han N, Xie F, Qiu G, Huang Z.
    Sci Rep; 2017 Mar 23; 7():45193. PubMed ID: 28332624
    [Abstract] [Full Text] [Related]

  • 2. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
    Yang JJ, Zhou C, Huang Y, Feng J, Lu S, Song Y, Huang C, Wu G, Zhang L, Cheng Y, Hu C, Chen G, Zhang L, Liu X, Yan HH, Tan FL, Zhong W, Wu YL.
    Lancet Respir Med; 2017 Sep 23; 5(9):707-716. PubMed ID: 28734822
    [Abstract] [Full Text] [Related]

  • 3. Effects of icotinib on advanced non-small cell lung cancer with different EGFR phenotypes.
    Pan H, Liu R, Li S, Fang H, Wang Z, Huang S, Zhou J.
    Cell Biochem Biophys; 2014 Sep 23; 70(1):553-8. PubMed ID: 24777808
    [Abstract] [Full Text] [Related]

  • 4. Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases.
    Magnuson WJ, Yeung JT, Guillod PD, Gettinger SN, Yu JB, Chiang VL.
    Int J Radiat Oncol Biol Phys; 2016 Jun 01; 95(2):673-9. PubMed ID: 27034176
    [Abstract] [Full Text] [Related]

  • 5. Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study.
    Zhou L, He J, Xiong W, Liu Y, Xiang J, Yu Q, Liang M, Zhou X, Ding Z, Huang M, Ren L, Zhu J, Li L, Hou M, Ding L, Tan F, Lu Y.
    Lung Cancer; 2016 Jun 01; 96():93-100. PubMed ID: 27133757
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of Icotinib, an EGFR Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients with Exon 19 Deletion and Exon 21 L858R: A Retrospective Analysis in China.
    Wang Y, Yuan X, Yang M, Shen Z, Chen H, He X, Ma Y, Ding L.
    Pharmacology; 2021 Jun 01; 106(11-12):658-666. PubMed ID: 34673645
    [Abstract] [Full Text] [Related]

  • 7. A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).
    Hu X, Han B, Gu A, Zhang Y, Jiao SC, Wang CL, He J, Jia X, Zhang L, Peng J, Wu M, Ying K, Wang J, Ma K, Zhang S, You C, Tan F, Wang Y, Ding L, Sun Y.
    Lung Cancer; 2014 Nov 01; 86(2):207-12. PubMed ID: 25261231
    [Abstract] [Full Text] [Related]

  • 8. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
    Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NG, Attia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL.
    J Clin Oncol; 2017 Apr 01; 35(10):1070-1077. PubMed ID: 28113019
    [Abstract] [Full Text] [Related]

  • 9. Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.
    Feng S, Wang Y, Cai K, Wu H, Xiong G, Wang H, Zhang Z.
    PLoS One; 2015 Apr 01; 10(10):e0140794. PubMed ID: 26474174
    [Abstract] [Full Text] [Related]

  • 10. Retrospective analysis of icotinib neoadjuvant therapy of 63 lung cancer patients.
    Wang T, Liu Y, Zhou B, Hao S, Wang Z, Liang N, Liu J, Wang S.
    Indian J Cancer; 2017 Apr 01; 54(1):215-222. PubMed ID: 29199694
    [Abstract] [Full Text] [Related]

  • 11. Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations.
    Gong L, Xiong M, Huang Z, Miao L, Fan Y.
    Lung Cancer; 2015 Sep 01; 89(3):268-73. PubMed ID: 26141219
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy of icotinib in lung cancer patients with different EGFR mutation status: a meta-analysis.
    Qu J, Wang YN, Xu P, Xiang DX, Yang R, Wei W, Qu Q.
    Oncotarget; 2017 May 16; 8(20):33961-33971. PubMed ID: 28430623
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis.
    Byeon S, Ham JS, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.
    Med Oncol; 2016 Aug 16; 33(8):97. PubMed ID: 27447711
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified].
    Song Z, Yu X, Cai J, Shao L, Lin B, He C, Zhang B, Zhang Y.
    Zhongguo Fei Ai Za Zhi; 2013 Mar 16; 16(3):138-43. PubMed ID: 23514942
    [Abstract] [Full Text] [Related]

  • 15. Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis.
    Hyun DG, Choi CM, Lee DH, Kim SW, Yoon S, Kim WS, Ji W, Lee JC.
    PLoS One; 2020 Mar 16; 15(4):e0231546. PubMed ID: 32298306
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of icotinib versus traditional chemotherapy as first-line treatment for preventing brain metastasis from advanced lung adenocarcinoma in patients with epidermal growth factor receptor-sensitive mutation.
    Zhao X, Zhu G, Chen H, Yang P, Li F, Du N.
    J Cancer Res Ther; 2016 Mar 16; 12(3):1127-1131. PubMed ID: 28054523
    [Abstract] [Full Text] [Related]

  • 17. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.
    Gui Q, Liu J, Li D, Xu C.
    World J Surg Oncol; 2017 Oct 16; 15(1):184. PubMed ID: 29037198
    [Abstract] [Full Text] [Related]

  • 18. A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer.
    Fan Y, Huang Z, Fang L, Miao L, Gong L, Yu H, Yang H, Lei T, Mao W.
    Cancer Chemother Pharmacol; 2015 Sep 16; 76(3):517-23. PubMed ID: 26148750
    [Abstract] [Full Text] [Related]

  • 19. Icotinib and whole-brain radiotherapy for the treatment in patients with brain metastases from EGFR-mutant nonsmall cell lung cancer: A retrospective study.
    Jiang AY, Zhang J, Luo HL, Gao F, Lv YF.
    Medicine (Baltimore); 2018 Apr 16; 97(15):e0312. PubMed ID: 29642161
    [Abstract] [Full Text] [Related]

  • 20. Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.
    Zhang Q, Zhang X, Yan H, Jiang B, Xu C, Yang J, Chen Z, Su J, Wu YL, Zhou Q.
    Thorac Cancer; 2016 Nov 16; 7(6):648-654. PubMed ID: 27755835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.